Abstract
The management of chronic migraine (CM) underwent a significant shift with the introduction of onabotulinumtoxin A (BoNT-A) injections following the landmark PREEMPT trial in 2010. Despite its efficacy, the existing injection protocol lacks precision, prompting a call for revision in light of modern ultrasound (US)-guided techniques. This article highlights the potential of US-guided injections to enhance accuracy, safety, and efficacy in CM treatment. By providing real-time visualization and addressing anatomical variations, US guidance offers a promising avenue for optimizing BoNT-A delivery, minimizing adverse effects, and ensuring therapeutic success.
| Original language | English |
|---|---|
| Pages (from-to) | 2001-2003 |
| Number of pages | 3 |
| Journal | Journal of Ultrasound in Medicine |
| Volume | 43 |
| Issue number | 10 |
| DOIs |
|
| Publication status | Published - Oct 2024 |
| Externally published | Yes |
Keywords
- botulinum
- headache
- injection
- migraine
- ultrasonography
Fingerprint
Dive into the research topics of '“Prompt” for PREEMPT: Dotting the I's and Crossing the T's With Ultrasound'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver